Severe anemia caused by parvovirus B19 in a patient with functioning kidney transplant: case report
https://doi.org/10.36485/1561-6274-2020-24-2-72-79
Abstract
Parvovirus B19 (PV B19) infection can cause pure red cell aplasia (PRCA) and severe normochromic anemia resistant to treatment with erythropoietin in renal transplant recipients. Active parvovirus infection usually develops in the first months after kidney transplantation (KT), but is not always accompanied by clinical symptoms. The incidence of PV B19-associated anemia is low - not more than 1–1.5 %. A confirmation of the etiology of the disease, in addition to the characteristic histological picture of the bone marrow (a decrease in the number of erythrokaryocytes of less than 5% with preserved myelopoiesis and megakaryopoiesis, the appearance of single giant pronormoblasts), is the detection of PV B19 DNA in the blood and / or bone marrow. The detection of specific IgM antibodies to parvovirus plays a less significant role in the diagnosis of active PV B19 infection in patients after KT receiving immunosuppressive therapy and should not be used as the only diagnostic method. There is no specific antiviral treatment for PV B19 infection, therefore other approaches to therapy are used: reduction of immunosuppression, transfusion of red blood cells, administration of intravenous immunoglobulin (IVIG). The article describes the clinical observation of a 33-year-old patient with stage 5 CKD who developed severe normochromic anemia resistant to treatment with erythropoietin 4 weeks after a successful KT. A cytological examination of the bone marrow revealed PRCA, and a large number of copies of PV B19 DNA were detected in the patient’s blood, while antibodies to parvovirus IgG and IgM were not revealed. A decrease of immunosuppression (withdrawal of mycophenolic acid), repeated administration of IVIG in a total dose of 147 g resulted to lasting normalization of red blood cells number and hemoglobin level after five months of treatment. The function of the renal transplant remained normal throughout the observation period.
About the Authors
E. Prokopenko
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Prof. Elena I. Prokopenko MD, PhD, DMedSci.
Postgraduate Medical Faculty, Department of transplantology, nephrology and artificial organs.
129110 Moscow, Shchepkin st., 61/2
Phone: (495)6845791
R. O. Kantariya
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Associate prof. Rusudana O. Kantariya MD, PhD.
Postgraduate Medical Faculty, Department of transplantology, nephrology and artificial organs.
129110 Moscow, Shchepkin st., 61/2
Phone: (495)6845791
A. V. Vatazin
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Prof. Andrey V. Vatazin MD, PhD, DMedSci.
Postgraduate Medical Faculty, Department of transplantology, nephrology and artificial organs.
129110 Moscow, Shchepkin st., 61/2
Phone: (495)6845453
S. A. Pasov
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Prof. Sergey A. Pasov MD, PhD, DMedSci
Postgraduate Medical Faculty, Department of transplantology, nephrology and artificial organs.
129110 Moscow, Shchepkin st., 61/2
Phone: (495)6845791
References
1. Otmakhova IA, Krasnov VV, Gadirova BYa et al. Parvovirus infection in adults: clinical manifestations and the importance of asymptomatic forms (clinical observation). Practical Medicine 2019; 17 (8): 121–124. (In Russ.)
2. Chernova ТM, Dubko MF. Parvovirus B19 as a cause of carditis in combination with myozitis. Med Sovet 2018; 2: 190–193. doi: 10.21518/2079-701X-2018-2-190-193 (In Russ.)
3. Bondarenko NP, Lakatosh VP, Belaya VV, Aksonova AV. Clinical and epidemiological aspects parvovirus B19 infection during pregnancy (clinical research). Women Health 2015; 6 (102): 89. (In Russ.)
4. Brennan DC. Introduction: kidney transplantation and viral infection. Semin Nephrol. 2016;36(5): 343. doi: 10.1016/j.semnephrol.2016.05.010
5. Prokopenko EI, Shcherbakova EO, Vatazin AV et al. Valganciclovir in cytomegalovirus prophylaxis in renal transplant recipients. Clinical Nephrology 2013; 5: 37–41. (In Russ.)
6. Porignaux R, Vuiblet V, Barbe C et al. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation. J Med Virol 2013; 85(6):1115–1121. doi: 10.1002/jmv.23557
7. Baral A, Poudel B, Agrawal RK et al. Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient. J Nepal Med Assoc 2012; 52(186):75–78. PMID: 23478734
8. Malbora B, Saritas S, Ataseven E et al. Pure red cell aplasia due to parvovirus B19: erythropoietin-resistant aAnemia in a pediatric kidney recipient. Exp Clin Transplant 2017; 15(3):369–371. doi: 10.6002/ect.2016.0263
9. Pabisiak K1 Stępniewska J, Ciechanowski K. Pure red cell aplasia after kidney transplantation: Parvovirus B19 culprit or coincidence? Ann Transplant 2019; 24:123–131. doi: 10.12659/AOT.913663
10. Luo Y, Kleiboeker S, Deng X, Qiu J. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. J Virol 2013; 87(23): 12766–12775. doi: 10.1128/JVI.02333-13
11. Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol 2016; 23: 5–12. doi: 10.1016/j.tracli.2015.11.006
12. Wu J, Chen X, Ye H et al. Nonstructural protein (NS1) of human parvovirus B19 stimulates host innate immunity and blunts the exogenous type I interferon signaling in vitro. Virus Res 2016; 222: 48–52. doi: 10.1016/j.virusres.2016.06.004
13. Baek CH, Kim H, Yang WS et al. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients. Transpl Infect Dis 2017; 19(5). doi: 10.1111/tid.12754
14. Hai An HP, Diem HT, Cuong NT. Parvovirus B19-Associated Anemia in Kidney Transplant Recipients: A Single-Center Experience. Transplant Proc 2019; 51(8):2693–2696. doi: 10.1016/j.transproceed.2019.03.076
15. Ki CS, Kim IS, Kim JW et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant 2005;19(6): 751–755. doi: 10.1111/j.1399-0012.2005.00415.x
16. Sim JY, Chang LY, Chen JM et al. Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect 2019; 52(4): 534–541. doi: 10.1016/j.jmii.2019.05.009
17. Bredl S, Plentz A, Wenzel JJ et al. False-negative serology in patients with acute parvovirus B19 infection. J Clin Virol 2011; 51(2):115–120. doi: 10.1016/j.jcv.2011.03.012
18. Kurtzman G, Frickhofen N, Kimball J et al. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321(8): 519–523. doi: 10.1056/NEJM198908243210807
19. Pakkyara A, Jha A, Al Salmi I et al. Persistent anemia in a kidney transplant recipient with parvovirus B19 infection. Saudi J Kidney Dis Transpl 2017; 28(6): 1447–1450. doi: 10.4103/13192442.220846
20. Kaya B, Paydas S. Recurrence of pure red cell aplasia in a kidney transplant recipient due to reactivation of parvovirus B19 infection despite two cycles of intravenous immunoglobulin therapy. Exp Clin Transplant 2019; 17(Suppl 1): 195–197. doi: 10.6002/ect.MESOT2018.P63
21. Rosado-Canto R, Carrillo-Pérez DL, Jiménez JV et al. Treatment strategies and outcome of parvovirus B19 infection in kidney transplant recipients: a case series and literature review of 128 patients. Rev Invest Clin 2019; 71(4):265–274. doi: 10.24875/RIC.19002921
22. Dzumabaeva BT, Birjukova LS, Kaplanskaya LB, Maksimov DP. The pure red blood cell aplasia in renal transplant recipient. Russian journal of transplantology and artificial organs 2011;13(2): 83–86. (In Russ.)
23. Berdinskij VA, Artjukhina LJu, Ivanova ES, Tomilina NA. Successful treatment of aplastic anemia induced parvovirus infection after kidney transplantation. Russian journal of transplantology and artificial organs 2016; 18 (S): 153. (In Russ.)
24. Gafter-Gvili A, Gafter U. Posttransplantation anemia in kidney transplant recipients. Acta Haematol 2019;142(1): 37–43. doi: 10.1159/000496140
25. Chang Y, Shah T, Min DI, Yang JW. Clinical risk factors associated with the post-transplant anemia in kidney transplant patients. Transpl Immunol 2016; 38: 50–53. doi: 10.1016/j.trim.2016.07.006
26. Bamgbola OF. Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications. Clin Transplant. 2016; 30(10): 1185–1194. doi: 10.1111/ctr.12813
27. Schechter A, Gafter-Gvili A, Shepshelovich D et al. Post renal transplant anemia: severity, causes and their association with graft and patient survival. BMC Nephrol 2019; 20(1): 51. doi: 10.1186/s12882-019-1244-y
28. Georges E, Rihova Z, Cmejla R et al. Parvovirus B19 induced lupus-like syndrome with nephritis. Acta Clin Belg 2016; 71(6): 423–425. doi: 10.1080/17843286.2015.1111673
29. Hara S, Hirata M, Ito K et al. Post-infectious acute glomerulonephritis with podocytopathy induced by parvovirus B19 infection. Pathol Int 2018; 68(3): 190–195. doi: 10.1111/pin.12643
30. Prasad N, Novak JE, Patel MR. Kidney diseases associated with parvovirus B19, hanta, ebola, and dengue virus infection: a brief review. Adv Chronic Kidney Dis 2019; 26(3): 207–219. doi: 10.1053/j.ackd.2019.01.006
31. Crabol Y, Terrier B, Rozenberg F et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis 2013; 56(7): 968–977. doi: 10.1093/cid/cis1046
32. Rivas-Delgado A, Matutes E, Rozman M. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection. Br J Haematol 2016; 172(4): 495. doi: 10.1111/bjh.13813
Review
For citations:
Prokopenko E., Kantariya R.O., Vatazin A.V., Pasov S.A. Severe anemia caused by parvovirus B19 in a patient with functioning kidney transplant: case report. Nephrology (Saint-Petersburg). 2020;24(2):72-79. (In Russ.) https://doi.org/10.36485/1561-6274-2020-24-2-72-79
Views:
1168
Email this article 